R

Research Management, Inc. | Kansas Nephrology Research Institute, LLC

Research site

(Unclaimed)

Location

1035 N. Emporia, Suite 158, Wichita, Kansas, United States of America

Site insights

Top conditions

Top treatments

Empagliflozin

BI 690517

Finerenone

Selonsertib

Vicadrostat

GS-4997

Bardoxolone Methyl

PF-00489791

Parent organization

This site is a part of Research Management, Inc.

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

Locations recently updated

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...

Not yet enrolling

Chronic Kidney Disease

Drug: Placebo matching vicadrostat

Drug: Vicadrostat

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD)

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting

Non-diabetic Chronic Kidney Disease

Drug: Finerenone (BAY94-8862)

Drug: Placebo

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study....

Enrolling

Kidney Disease, Chronic

Drug: Placebo matching BI 690517

Drug: Empagliflozin